Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C22H18FN5O2 |
Molecular Weight | 403.409 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@]12COC3=C1C(CNC4=C(OC2)C=C(C5=NN=CN45)C6=C(C)N=CC=C6)=C(F)C=C3
InChI
InChIKey=JQBUTSBIFNKJMW-CYBMUJFWSA-N
InChI=1S/C22H18FN5O2/c1-12-14(3-2-6-24-12)15-7-19-22(28-11-26-27-21(15)28)25-8-16-17(23)4-5-18-20(16)13(9-29-18)10-30-19/h2-7,11,13,25H,8-10H2,1H3/t13-/m1/s1
Molecular Formula | C22H18FN5O2 |
Molecular Weight | 403.409 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 19:15:29 GMT 2023
by
admin
on
Sat Dec 16 19:15:29 GMT 2023
|
Record UNII |
BC2SSV7WMT
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
FDA ORPHAN DRUG |
862121
Created by
admin on Sat Dec 16 19:15:29 GMT 2023 , Edited by admin on Sat Dec 16 19:15:29 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
2490674-02-5
Created by
admin on Sat Dec 16 19:15:29 GMT 2023 , Edited by admin on Sat Dec 16 19:15:29 GMT 2023
|
PRIMARY | |||
|
BC2SSV7WMT
Created by
admin on Sat Dec 16 19:15:29 GMT 2023 , Edited by admin on Sat Dec 16 19:15:29 GMT 2023
|
PRIMARY | |||
|
12321
Created by
admin on Sat Dec 16 19:15:29 GMT 2023 , Edited by admin on Sat Dec 16 19:15:29 GMT 2023
|
PRIMARY | |||
|
LM-160
Created by
admin on Sat Dec 16 19:15:29 GMT 2023 , Edited by admin on Sat Dec 16 19:15:29 GMT 2023
|
PRIMARY | |||
|
C190423
Created by
admin on Sat Dec 16 19:15:29 GMT 2023 , Edited by admin on Sat Dec 16 19:15:29 GMT 2023
|
PRIMARY | |||
|
155128494
Created by
admin on Sat Dec 16 19:15:29 GMT 2023 , Edited by admin on Sat Dec 16 19:15:29 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ENANTIOMER -> ENANTIOMER |
|
||
|
TARGET -> INHIBITOR |
FTX-6058 acts via inhibition of the polycomb repressive complex 2 (PRC2) through binding to the embryonic ectoderm development (EED) subunit. A 2-3 fold increase in fetal hemoglobulin sysnthesiswhen treated.
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
FTX-6058 is an inducer of fetal hemoglobin via EED binding and PRC2 modulation.
|